CIBC Bancorp USA’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.32M Sell
25,312
-5,097
-17% -$1.13M 0.01% 730
2026
Q2
$6.4M Sell
30,409
-4,561
-13% -$978K 0.01% 671
2026
Q1
$7.73M Buy
+34,970
New +$8.55M 0.01% 587
2025
Q3
$3.36M Buy
+13,584
New +$3.25M 0.02% 487

Other funds holding STE

CIBC Bancorp USA's STE Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Steris (STE) stake by 17% in Q3 2026, selling an estimated $1.13M and leaving 25,312 shares worth $5.32M. The position accounts for 0.01% of the portfolio, ranked #730.

CIBC Bancorp USA first reported a position in STE in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.73M in Q1 2026. 811 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • CIBC Bancorp USA held 25,312 shares of Steris worth $5.32M as of Q3 2026.
  • CIBC Bancorp USA sold 5,097 Steris shares in Q3 2026, an estimated $1.13M.
  • Steris made up 0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #730 holding.
  • CIBC Bancorp USA first reported a position in Steris in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Steris position peaked at $7.73M in Q1 2026.
  • 811 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.